- Kids’ ER Visits for Injuries Rose During Lockdown, While Non-Injury Cases Fell
- Estrogen Taken During Gender-Affirming Surgeries Won’t Raise Blood Clot Risk: Study
- During Lockdowns, Women Took on Most of Burden of Child Care
- As More Legal Pot Dispensaries Open, More Young Adults Start Using
- Vision Problems? Here’s a Guide to Which Specialist Is Right for You
- Biden Outlines ‘Bold’ National Vaccine Effort
- COVID Pandemic Shortened U.S. Life Expectancy by More Than a Year
- Should Your Child Get a COVID Test?
- AHA News: What Heart and Stroke Patients Should Know About COVID-19 Vaccines
- New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue
Study Touts Success With 'Female Viagra' Drug
MONDAY, Nov. 16New industry-funded research suggests that the antidepressant flibanserin, which has been touted as a female version of Viagra, can enhance libido in women with low sex drives.
The research compiles the results of several trials, the first to test a treatment for low libido in women that works on the brain, lead investigator Dr. John M. Thorp Jr., a professor of obstetrics and gynecology at the University of North Carolina at Chapel Hill School of Medicine, said in a university news release.
“Flibanserin was a poor antidepressant,” Thorp said. “However, astute observers noted that it increased libido in laboratory animals and human subjects. So, we conducted multiple clinical trials, and the women in our studies who took it for hypoactive sexual desire disorder reported significant improvements in sexual desire and satisfactory sexual experiences.”
Research suggests that 9 percent to 26 percent of women in the United States suffer from low sex drive, with the numbers varying depending on age and whether they’ve reached menopause.
The findings were to be presented Monday at the Congress of the European Society for Sexual Medicine in Lyon, France.
The researchers combined statistics from three trials of flibanserin, which together included 1,946 premenopausal women who took either the drug or a placebo for about six months.
Daily doses of 100 milligrams significantly improved symptoms, the researchers found.
Boehringer Ingelheim, which makes flibanserin, funded the research.
More information
The American Congress of Obstetricians and Gynecologists has more on women’s sexuality and sexual problems.
Source: HealthDay
